17 January 2018

On 1 and 2 November the 12th edition of the Radboud New Frontiers symposium will take place. During the first day of this symposium we will explore what big data and healthcare data science have to offer for personalized healthcare. This day is targeted at researchers but open for everyone with interest in the subject. Registration will open soon!

With new scientific insights and increasing technological possibilities medical research is rapidly changing. Increased computer capacity, availability of data and connectivity between databases enable big data analysis and have propelled the development of fields such as multi-omics, network medicine and computational medicine. In combination with demographic changes such as the rise of lifestyle related and chronic diseases, insights derived from the application of these new methodologies change the way we look at diseases: what once was one disease increasingly turns out to be a collection of entities with their own etiology, diagnosis and treatment. Vice versa, we begin to understand how health and disease are inherently multiscale phenomena that emerge out of complex and dynamic interactions within and between a person and his environment. Technologies like lab on a chip and self measurement with all kind of sensors change the way we collect data to make a diagnosis and the way we monitor diseases. In the background we see that the complexity of healthcare delivery and organisation has increased, not always in favour of the patient. However, the essence of medicine remained; the impact on patients’ lives of being confronted with illness and the importance of the caring relationship in a patient journey.

In this context, the topic of this conference is to explore what big data and healthcare data science have to offer for (research into) personalized healthcare:
  • what is the potential promise of big data application to healthcare;
  • what are examples of successful application of data science and how can these be applied to benefit health;
  • what are the technical, organizational, ethical and epistemological limitations of the application of data science in the field of health;
  • and will big data help to bridge the divide between medicine-as-a-science and medicine-as-an-art, and improve the individual patient journey?
The day will begin with an inspiring peek into the future promise of big data application to healthcare, that will be followed by several high quality examples of applications of data science to health and care.  These examples will present some key methodological aspects/principles of data science. The second part of the day will explore the boundaries of big data and healthcare data science from the technical, ethical and clinical perspective.  
 

Related news items


Frank Walboomers 25-years work anniversary at Radboudumc

17 September 2020

Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.

read more

Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes

17 September 2020

Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.

read more

Annette Schenck appointed professor of Translational Genetics

17 September 2020

Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.

read more

Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients

17 September 2020

Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.

read more

Radboudumc does large-scale research on systemic sclerosis

10 September 2020

In rare diseases, such as systemic sclerosis, it’s often difficult to conduct large-scale research. Rheumatologist Madelon Vonk has managed to follow enough patients with systemic sclerosis for years. The results of her research have been published in BMJ Annal of the Rheumatic Diseases.

read more